Eisai Ltd v National Institute for Health & Clinical Excellence (NICE) & (1) Alzheimer's Society (2) Shire Pharmaceuticals Ltd (Interested Parties)

Judicial review case, in connection with the procedures of the National Institute of Clinical Excellence (“NICE”), which established that NICE’s guidance on NHS-rationing of Alzheimer’s drugs breached race discrimination duties. The claim succeeded on limited grounds.

Mike Fordham QC acted for the Alzheimer’s Society; David Pannick QC and Tom de la Mare advised Eisai and Pfizer.